Stocks Making The Biggest Moves: Boeing, SAP, Lemonade, Alibaba And More

Stocks Making The Biggest Moves: Boeing, SAP, Lemonade, Alibaba And More Shares of SAP - German business software company soared after the Qualtrics unit announced that it went public. Qualtrics, which specialize in customer relationship software, are expected to generate around $ 12 billion or more. SAP paid $ 8 billion for the Qualtrics acquisition 2 years ago. Boeing - Boeing is closely watching the American Airlines flight from Miami to New York, the first US airline to return to service. The reason is that the revised 737 Max jet is used in this flight. Jet's flights were suspended after two fatal accidents in early 2019. Boeing shares rose 1.5 percent. Cisco Systems - Cisco spokesperson told the Wall Street Journal they are igniting the "Smart Cities" project called "Cisco Kinetic for Cities". The project is seen as part of Cisco's effort to expand its more lucrative software services business beyond traditional network equipment and hardware. Target - Target sold the Dermstore operation to UK-based online retailer THG Holdings for $ 350 million in cash. Dermstore is an online retailer of skincare and beauty products. Target shares were gradually higher around 7:45 AM ET. Barnes & Noble Education -The online book retail chain is expected to continue its recent cost reduction efforts, Finance Director Thomas Donohue interviewed with the Wall Street Journal. Efforts to reduce costs are made by foreseeing another period of distance learning. The company's shares rose by approximately 13 percent around 7:45 AM ET. Alibaba - China-based e-commerce company Alibaba continues to stand vigil, gaining a slight increase on Monday after a 13.3 percent drop last Thursday. The decline came amid growing competition scrutiny from Chinese regulators (regulators). Alibaba shares gained 3 percent as of 07:45 ET. Lemonade - Nearly 44 million shares of the online insurance company will become available for sale today as the lockdown period on member sales has ended. The stock fell sharply in the last two trading days in expectation, shedding about 7 percent last Thursday and another 14 percent yesterday. As of 07:45 ET, the stock lost another 4.5 percent. Alkermes - FDA said the Dublin-based biopharmaceutical company has agreed to reintroduce the drug known as ALKS 3831, which it has issued for schizophrenia and certain types of bipolar disorder in adults. The company was problematic after the FDA reviewed the Alkermes manufacturing facility in Ohio. It was stated that there was no problem and the company would not have to do a new trial. The company's shares rose 3 percent around 7:45 AM ET. Bausch Health - The drug maker said it plans to repay $ 275 million in debt using the cash on hand and cash from its operations. Arcturus Therapeutics - San Diego-based biotech company shares fell more than 35 percent in pre-market trading following the release of data on the Covid-19 vaccine candidate. This decline took place, although Arcturus said it had positive work results. The company announced that it will see phase 3 trials that will take place in the second quarter of 2021. Fiat Chrysler - Poland's deputy prime minister, Jaroslaw Gowin, plans to invest about $ 2.5 billion in the automaker's factory in Tychy, Poland. The facility will be modernized to produce hybrid and electric versions of Jeep, Fiat and Alfa Romeo models. Fiat Chrysler's shares gained 1 percent as of 7:45 AM ET.     Source: https://www.cnbc.com/ You may also be interested in: Bitcoin could breathe in 2021